Back

Combination of single cell sequencing data and GWAS summary statistics reveals genetically-influenced liver cell types for primary biliary cholangitis

Xiang, B.; Deng, C.; Li, J.; Li, S.; Zhang, H.; Lin, X.; Lu, M.; Ma, Y.

2021-08-24 genetic and genomic medicine
10.1101/2021.08.18.21262250 medRxiv
Show abstract

ImportancePrimary biliary cholangitis (PBC) is a classical autoimmune disease, which is highly influenced by genetic determinants. Many genome-wide association studies (GWAS) have reported that numerous genetic loci were significantly associated with PBC susceptibility. However, the effects of genetic determinants on liver cells and its immune microenvironment for PBC remain unclear. ObjectiveTo identify genetics-modulated functional liver cell subsets involved in the pathogenesis of PBC. Design, Setting, and ParticipantsIn this present study, 13,239 European participants were collected from IEU open GWAS project on PBC. There were 1,124,241 qualified SNPs used for GWAS analysis. Expression quantitative trait loci (eQTL) data across 49 tissues were downloaded from the GTEx database. Two single cell RNA sequencing (scRNA-seq) profiles and two bulk-based RNA transcriptomes were downloaded from the GEO database. Data collection and analyses were performed from August 2020 to June 2021. Main outcomes and measuresWe constructed a powerful computational framework to integrate GWAS summary statistics with scRNA-seq data to uncover genetics-modulated liver cell subpopulations. ResultsBased on our multi-omics integrative analysis, we found that 29 risk genes including ORMDL3, GSNK2B, and DDAH2 were significantly associated with PBC susceptibility. Gene-property analysis revealed that four immune cell types, including Cst3+ dendritic cell, Chil3+ macrophage, Trbc2+ T cell, and Gzma+ T cell, were significantly enriched by PBC-risk genes. By combining GWAS summary statistics with scRNA-seq data, we found that cholangiocytes exhibited a notable enrichment by PBC-related genetic association signals (Permuted P < 0.05). The risk gene of ORMDL3 showed the highest expression proportion in cholangiocytes than other liver cells (22.38%). Compared with ORMDL3+ cholangiocytes, there were 71 significantly highly-expressed genes among ORMDL3- cholangiocytes (FDR < 0.05), such as inflammatory cytokine genes CXCL8, CCL3, IFI16, and IRF1. These highly-expressed genes were significantly enriched in numerous biological pathways and functional terms associated with autoimmune diseases (FDR < 0.05). Conclusions and relevanceTo the best of our knowledge, this is the first study to integrate genetic information with single cell sequencing data for parsing genetics-influenced liver cells for PBC risk. We identified that ORMDL3- cholangiocytes play important immune-modulatory roles in the etiology of PBC. Key pointsO_ST_ABSQuestionC_ST_ABSAre genetics factors influenced liver cell subpopulations and its immune microenvironment for PBC? FindingsIn this comprehensive genomics study based on multi-omics data, genetic determinants were significantly enriched in cholangiocytes and immune cells including subsets of macrophage, dendritic cells, and T cells. ORMDL3- cholangiocytes have crucial immune-modulatory roles in developing PBC. MeaningFindings suggest that integration of single cell sequencing data with GWAS summary statistics contribute to pinpoint PBC-relevant cell types and risk genes.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Human Genetics and Genomics Advances
84 papers in training set
Top 0.2%
7.1%
2
eBioMedicine
183 papers in training set
Top 0.4%
5.4%
3
eLife
5828 papers in training set
Top 22%
5.4%
4
iScience
1154 papers in training set
Top 2%
5.4%
5
Scientific Reports
3612 papers in training set
Top 19%
5.1%
6
Frontiers in Genetics
230 papers in training set
Top 0.6%
4.8%
7
Genome Medicine
183 papers in training set
Top 0.9%
4.3%
8
Cell Genomics
172 papers in training set
Top 0.9%
4.0%
9
Nature Communications
5641 papers in training set
Top 33%
4.0%
10
Cell & Bioscience
14 papers in training set
Top 0.1%
3.2%
11
Briefings in Bioinformatics
354 papers in training set
Top 3%
3.2%
50% of probability mass above
12
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.1%
3.2%
13
Cell Death & Disease
126 papers in training set
Top 0.8%
3.1%
14
Communications Biology
993 papers in training set
Top 9%
2.3%
15
Molecular Medicine
11 papers in training set
Top 0.1%
2.1%
16
Journal of Personalized Medicine
28 papers in training set
Top 0.3%
1.9%
17
Frontiers in Immunology
638 papers in training set
Top 5%
1.9%
18
Human Genetics
28 papers in training set
Top 0.3%
1.7%
19
Journal of Hepatology
21 papers in training set
Top 0.3%
1.7%
20
Gut
40 papers in training set
Top 0.6%
1.5%
21
Hepatology Communications
22 papers in training set
Top 0.3%
1.1%
22
International Journal of Molecular Sciences
494 papers in training set
Top 12%
1.1%
23
Clinical and Translational Medicine
31 papers in training set
Top 0.6%
1.0%
24
The American Journal of Human Genetics
234 papers in training set
Top 2%
1.0%
25
PLOS Genetics
862 papers in training set
Top 11%
1.0%
26
Cell Proliferation
12 papers in training set
Top 0.2%
0.9%
27
Genomics
64 papers in training set
Top 2%
0.8%
28
BMC Genomics
406 papers in training set
Top 8%
0.8%
29
Frontiers in Oncology
103 papers in training set
Top 3%
0.8%
30
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 2%
0.6%